Feb 10, 2017
Haydn Evans looks at the role of intellectual property (IP) management in protecting pharmaceutical company products.
Feb 09, 2017
Pharmaceutical Executive
Keith Bailey offers a new approach to reviving industry collaborations.
Feb 08, 2017
Pharmaceutical Executive
The key steps to easing rising complexity and cost factors.
Jan 11, 2017
How can Pharma balance the need to access to patient data and still respect patient privacy? One approach is to access patients through third-party online communities, writes Peter Houston.
Dec 18, 2016
Pharmaceutical Executive
In a continent marked by stark differences in governance, growth and market potential, the best bets must be pursued off script.
Dec 12, 2016
Pharmaceutical Executive
How a Manufacturing Excellence program can deliver competitive advantage to a fast-changing global product mix—at lower cost, and with an unexpected workforce dividend to boot.
Nov 29, 2016
However conservative and heavily regulated the drugs business, it too must transform itself to exploit digital opportunities — if only to ward off disruption, says Elvis Paćelat.
Nov 11, 2016
Pharmaceutical Executive
An industry-based working group presents a common standards and definition framework for “Access” competencies in pharma.
Nov 11, 2016
Pharmaceutical Executive
Biopharma companies are increasingly leveraging product portfolios to own and dominate strategically important therapeutic areas,, writes Stan Bernard.
Nov 09, 2016
Pharmaceutical Executive
Loss of exclusivity (LOE) doesn’t have to be the death knell for branded drug revenue streams. The key approaches to preserving meaningful value well into the post-patent-loss future are outlined.
lorem ipsum